SecBot SecBot
SECBOTREPLAY Home › Report › KPTI

KPTI · Karyopharm filed an S-3 shelf registration for the resale of up to…

Karyopharm Therapeutics Inc. · S-3 filed May 4, 2026 at 16:37 ET

At the news

NEUTRALIMPACT 3/10

S-3 filed May 4, 2026 at 16:37 ET

Karyopharm filed an S-3 shelf registration for the resale of up to 8,843,036 shares by RA Capital Healthcare Fund, consisting of 1,030,354 outstanding shares, 3,391,164 pre-funded warrant shares, and 4,421,518 common stock warrant shares. The company will receive no proceeds from this resale; the filing fulfills registration rights granted in the March 2026 private placement that raised $30M. The common stock warrants have a $10 exercise price (currently out of the money at $8.40), so near-term selling is likely limited to the already-issued shares.

  • Registration covers 1,030,354 outstanding shares, 3,391,164 pre-funded warrant shares (exercise $0.0001), and 4,421,518 common stock warrant shares (exercise $10.00).
  • Company receives no proceeds from resale; gross proceeds from original March 2026 private placement were $30M.
  • Common stock warrants are out of the money (exercise $10 vs. current $8.40).
  • RA Capital is currently limited to beneficial ownership of 9.99% (2,290,108 shares) but may increase that limit upon 61 days' notice.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access